Litcius/Paper detail

Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12

Christopher Garris, Sean P. Arlauckas, Rainer H. Köhler, Marcel P. Trefny, Seth Garren, Cécile Piot, Camilla Engblom, Christina Pfirschke, Marie Siwicki, Jeremy Gungabeesoon, Gordon J. Freeman, Sarah E. Warren, SuFey Ong, Erica Browning, Christopher G. Twitty, Robert H. Pierce, Mai H. Le, Alain P. Algazi, Adil Daud, Sara I. Pai, Alfred Zippelius, Ralph Weissleder, Mikaël J. Pittet

2022Immunity43 citationsDOIOpen Access PDF

Topics & Concepts

ImmunotherapyCrosstalkDendritic cellCancer immunotherapyBiologyT cellCancer researchImmunologyImmune systemOpticsPhysicsCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesCAR-T cell therapy research
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12 | Litcius